Meet our speakers

Dr. Jeremy Jenkins

US Head Discovery Sciences • Novartis

Dr. Jenkins, US Head Discovery Sciences, is a leader in AI-driven drug discovery, leveraging generative models and machine learning to revolutionize target identification, small-molecule design, and assay development for breakthrough therapeutics.

Dr. James Collins

Termeer Professor • MIT

Dr. Collins, Termeer Professor at MIT and a pioneer of synthetic biology, is a world-renowned scientist leveraging AI to revolutionize antibiotic discovery and develop breakthrough medical technologies.

Dr. Mikael Dolsten

CSO (2010-2024) • Pfizer

Dr. Dolsten, former Chief Scientific Officer at Pfizer, is a visionary biopharmaceutical leader who spearheaded the development of Pfizer's COVID-19 vaccine while driving breakthroughs in oncology, immunology, and precision medicine.

Dr. Anne Granger

Editor-in-Chief • BioRender

Before joining BioRender as first Editor in Chief, Dr. Anne Granger served as a Senior Editor at Cell Press (Cell Metabolism) and led the postdoctoral program at Novartis Biomedical Research.

Shiz Aoki

CEO and Co-founder • BioRender

Shiz Aoki, CEO and Co-Founder of BioRender, is a globally recognized leader in scientific visualization and former lead medical illustrator at National Geographic, transforming how scientists communicate complex research.

Event Agenda

• KEYNOTE

  Generative AI in Drug Discovery

  Dr. Jeremy Jenkins
  Dr. Jeremy Jenkins will share how generative AI is transforming drug discovery—accelerating target identification, small-molecule design, and assay development. He’ll showcase real-world breakthroughs and explain how AI is breaking traditional barriers in pharmaceutical R&D, paving the way for faster, more effective treatments.

• Expert Panel and Q&A

  Dr. James Collins, Dr. Jeremy Jenkins, and Dr. Mikael Dolsten; Moderated by Dr. Anne Granger
  This expert panel unites leaders in AI-driven drug discovery: Dr. James Collins, Dr. Jeremy Jenkins, and Dr. Mikael Dolsten. They'll discuss how AI is transforming pharmaceutical research from early discovery to clinical trials, followed by an audience Q&A.

• BioRender AI: Next-Gen Tools for Scientific Communication

  Shiz Aoki
  Shiz Aoki unveils BioRender's latest suite of AI tools, designed to help scientists collaborate on complex ideas. Whether for stage-gate meetings, presentations, or critical research documents, BioRender puts powerful visual tools at your fingertips—making scientific communication faster and more effective.